This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Kagan, V. E. Articles by Yalowich, J. C. Search for Related Content PubMed PubMed Citation Articles by Kagan, V. E. Articles by Yalowich, J. C.

Pro-oxidant and Antioxidant Mechanisms of Etoposide in HL-60 Cells

Role of Myeloperoxidase¹

Departments of Environmental and Occupational Health [V. E. K., A. I. K., Y. Y. T., T. M.] and Pharmacology [V. E. K., A. I. K., T. M., J. C. Y.], University of Pittsburgh, Pittsburgh, Pennsylvania 15238; Health Effects Laboratory Division, Pathology and Physiology Research Branch, National Institute for Occupational Safety and Health, Morgantown, West Virginia 26505 [A. A. S.]; and A.V. Palladin Institute of Biochemistry, Ukrainian National Academy of Sciences, Kiev, 252030, Ukraine [A. I. K.]

Etoposide is an effective anticancer agent whose antitumor activity is associated with its phenolic E-ring, which can participate in intracellular redox cycling reactions. Myeloperoxidase (MPO)-catalyzed one-electron oxidation of the etoposide phenolic ring and/or interaction of this phenolic moiety with reactive radicals yields its phenoxyl radical, whose reactivity may determine the pro- or antioxidant effects of this molecule in cells. Using MPO-rich HL-60 cells, we directly demonstrated that both anti- and pro-oxidant activities of etoposide are realized in cells. Etoposide acted as an effective radical scavenger and antioxidant protector of phosphatidylethanolamine, phosphatidylcholine, and other intracellular phospholipids against H₂O₂-induced oxidation in HL-60 cells with constitutively high MPO activity and in HL-60 cells depleted of MPO by an inhibitor of heme synthesis, succinyl acetone. MPO-catalyzed production of etoposide phenoxyl radicals observed directly in HL-60 cells by electron paramagnetic resonance (EPR) did not result in oxidation of these membrane phospholipids, suggesting that the radicals were not reactive enough to trigger lipid oxidation. MPO-dependent pro-oxidant activity of etoposide was directly demonstrated by (a) the ability of intracellular reduced glutathione (GSH) to eliminate EPR-detectable etoposide phenoxyl radicals, (b) the ability of etoposide phenoxyl radicals to oxidize GSH and protein thiols (after preliminary depletion of intracellular GSH with a maleimide reagent, ThioGlo-1), and (c) the disappearance of these effects after depletion of MPO by pretreatment of cells with succinyl acetone. In addition, titration of intracellular GSH (in intact cells) using the maleimide reagent ThioGlo-1 resulted in remarkably augmented EPR-detectable etoposide phenoxyl radicals and enhanced etoposide-induced topoisomerase II-DNA covalent complexes. In conclusion, the phenolic moiety of etoposide acts as an effective free radical scavenger, accounting for its antioxidant action. Whereas one-electron oxidation of etoposide by free radical scavenging and/or by MPO results in a phenoxyl radical with low reactivity toward lipids, its high reactivity toward thiols is a determinant of its pro-oxidant effects in HL-60 cells.

This article has been cited by other articles:

				Y. Y. Tyurina, V. Kini, V. A. Tyurin, I. I. Vlasova, J. Jiang, A. A. Kapralov, N. A. Belikova, J. C. Yalowich, I. V. Kurnikov, and V. E. Kagan Mechanisms of Cardiolipin Oxidation by Cytochrome c: Relevance to Pro- and Antiapoptotic Functions of Etoposide Mol. Pharmacol., August 1, 2006; 70(2): 706 - 717. [Abstract] [Full Text] [PDF]

				B. B. Hasinoff, X. Wu, O. V. Krokhin, W. Ens, K. G. Standing, J. L. Nitiss, T. Sivaram, A. Giorgianni, S. Yang, Y. Jiang, et al. Biochemical and Proteomics Approaches to Characterize Topoisomerase II{alpha} Cysteines and DNA as Targets Responsible for Cisplatin-Induced Inhibition of Topoisomerase II{alpha} Mol. Pharmacol., March 1, 2005; 67(3): 937 - 947. [Abstract] [Full Text] [PDF]

				M. Darst, M. Al-Hassani, T. Li, Q. Yi, J. M. Travers, D. A. Lewis, and J. B. Travers Augmentation of Chemotherapy-Induced Cytokine Production by Expression of the Platelet-Activating Factor Receptor in a Human Epithelial Carcinoma Cell Line J. Immunol., May 15, 2004; 172(10): 6330 - 6335. [Abstract] [Full Text] [PDF]

				Y. Y. Tyurina, F. B. Serinkan, V. A. Tyurin, V. Kini, J. C. Yalowich, A. J. Schroit, B. Fadeel, and V. E. Kagan Lipid Antioxidant, Etoposide, Inhibits Phosphatidylserine Externalization and Macrophage Clearance of Apoptotic Cells by Preventing Phosphatidylserine Oxidation J. Biol. Chem., February 13, 2004; 279(7): 6056 - 6064. [Abstract] [Full Text] [PDF]

				M. Corazzari, P. E. Lovat, S. Oliverio, A. D. J. Pearson, M. Piacentini, and C. P. F. Redfern Growth and DNA Damage-Inducible Transcription Factor 153 Mediates Apoptosis in Response to Fenretinide but Not Synergy between Fenretinide and Chemotherapeutic Drugs in Neuroblastoma Mol. Pharmacol., December 1, 2003; 64(6): 1370 - 1378. [Abstract] [Full Text] [PDF]

				R. Shimoda, W. E. Achanzar, W. Qu, T. Nagamine, H. Takagi, M. Mori, and M. P. Waalkes Metallothionein Is a Potential Negative Regulator of Apoptosis Toxicol. Sci., June 1, 2003; 73(2): 294 - 300. [Abstract] [Full Text] [PDF]

				T. Li, M. D. Southall, Q. Yi, Y. Pei, D. Lewis, M. Al-Hassani, D. Spandau, and J. B. Travers The Epidermal Platelet-activating Factor Receptor Augments Chemotherapy-induced Apoptosis in Human Carcinoma Cell Lines J. Biol. Chem., May 2, 2003; 278(19): 16614 - 16621. [Abstract] [Full Text] [PDF]

				S. Kumar, N. Mishra, D. Raina, S. Saxena, and D. Kufe Abrogation of the Cell Death Response to Oxidative Stress by the c-Abl Tyrosine Kinase Inhibitor STI571 Mol. Pharmacol., February 1, 2003; 63(2): 276 - 282. [Abstract] [Full Text] [PDF]